Predict your next investment

HEALTHCARE | Drug Development

See what CB Insights has to offer


Seed VC | Alive

Total Raised


Last Raised

$13.06M | 4 yrs ago

About Critical Pressure

Developer of therapeutics for vascular dysfunction and shocks. The company is developing a new drug to help patients in intensive care with severe sepsis. Sepsis is caused by a bacterial infection, usually with bacteria resistant to antibiotics.

Critical Pressure Headquarter Location

Care of The Cambridge Partnership Babraham Research, Campus Babraham

Cambridge, CB22 3AT,

United Kingdom

44 1223 834510

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Critical Pressure

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Critical Pressure is included in 1 Expert Collection, including Biopharmaceuticals.



5,726 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.